Form 4: Allogene Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Earl Martin Douglas, SVP, General Counsel of Allogene Therapeutics, Inc., sold 29,697 shares of common stock on August 21, 2026 for $2.12 per share.
Summary
- Open-market sale: disposed of 29,697 Common Stock at $2.12 ($62,958) on August 21, 2026; holds 488,267 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $62,958 of stock on the open market.
Insider Transactions
Earl Martin Douglas — Officer (SVP, General Counsel)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Open-market sale | Common Stock | 29,697 | $2 | $63.0K | 488,267 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Open-market sale (29,697 shares) |
Keywords
insider transaction, Form 4, ALLO, Allogene Therapeutics, Inc., bearish, Earl Martin Douglas
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.